ORBi: Boonen Steven - Antifracture efficacy and safety of once-yearly Zoledronic acid 5mg in men with osteoporosis: a prospective, randomized, controlled trial

Reference : Antifracture efficacy and safety of once-yearly Zoledronic acid 5mg in men with osteopor...


	Document type :	Scientific congresses and symposiums : Paper published in a journal
	Discipline(s) :	Human health sciences : Public health, health care sciences & services Human health sciences : General & internal medicine
	To cite this reference:	http://hdl.handle.net/2268/88516

Title :	Antifracture efficacy and safety of once-yearly Zoledronic acid 5mg in men with osteoporosis: a prospective, randomized, controlled trial
Language :	English
Author, co-author :	Boonen, Steven [ > > ]
	Su, Guoqin [ > > ]
	Incera, Elodie [ > > ]
	Orwoll, Eric [ > > ]
	Kaufman, Jean-Marc [ > > ]
	Reginster, Jean-Yves [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
	Rizzoli, René [ > > ]
	Lippuner, Kurt [ > > ]
	Vanderschueren, Dirk [ > > ]
	Bucci-Rechtweg, Christina [ > > ]
	Antunez, Oscar [ > > ]
	Papanastasiou, Phil [ > > ]
Publication date :	Mar-2011
Journal title :	Osteoporosis International
Publisher :	Springer Science & Business Media B.V.
Volume :	22
Issue/season :	Suppl.1
Pages :	S112
On invitation :	No
Audience :	International
ISSN :	0937-941X
e-ISSN :	1433-2965
City :	Godalming
Country :	United Kingdom
Event name :	European Congress on Osteoporosis and Osteoarthritis ECCEO11-IOF
Event date :	du 23 mars 2011 au 26 mars 2011
Event organizer :	International Osteoporosis Foundation and National Osteoporosis Foundation 2011
Event place (city) :	Valencia
Event country :	Spain
Permalink :	http://hdl.handle.net/2268/88516

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Restricted access	OC35.pdf		Publisher postprint	39.72 kB	Request copy

All documents in ORBi are protected by a user license.